Peter Auguste

1.3k citations

44 papers · 857 indexed · h-index 17

Impact in

Critical Care and Intensive Care Medicine top 10%
Microbiology top 10%
- Reproductive tract infections research

Papers in ⓘ

Radiology, Nuclear Medicine and Imaging 10
- Radiomics and Machine Learning in Medical Imaging 6
Epidemiology 14
- Pneumonia and Respiratory Infections 3

Co-authors: Tracy Roberts (8 shared papers)Rachel Court (15 shared papers)Aileen Clarke (11 shared papers)Paul Sutcliffe (7 shared papers)Alexander Tsertsvadze (7 shared papers)Pelham Barton (5 shared papers)Joshua Pink (5 shared papers)Hema Mistry (8 shared papers)
Journals: Health Technology Assessment (11 papers)BMJ Open (4 papers)PharmacoEconomics (2 papers)BJOG An International Journal of Obstetrics & Gynaecology (2 papers)International Journal of Technology Assessment in Health Care (2 papers)
Partner nations: United Kingdom France Switzerland

In The Last Decade

Peter Auguste

36 papers receiving 830 citations

Peers

Countries citing papers authored by Peter Auguste

Since Specialization

Citations

This map shows the geographic impact of Peter Auguste's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Auguste with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Auguste more than expected).

Fields of papers citing papers by Peter Auguste

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Auguste. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Auguste. The network helps show where Peter Auguste may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Auguste, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Auguste Line = papers co-authored together Peter Auguste links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness. Health Technology Assessment ·Andrew K Ewer, AT Furmston, Lee Middleton, Jonathan J Deeks, Jane Daniels, Helen Pattison, Rachael Powell, Tracy Roberts, Pelham Barton, Peter Auguste, A. Bhoyar, Shakila Thangaratinam, AM Tonks, Prakash Satodia, Shriprasad R. Deshpande, Babu Kumararatne, S Sivakumar, Richard Mupanemunda, Khalid S. Khan	2012	109
2	Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis BMC Infectious Diseases ·Peter Auguste, Alexander Tsertsvadze, Joshua Pink, Rachel Court, Noel McCarthy, Paul Sutcliffe, Aileen Clarke	2017	106
3	Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation Health Technology Assessment ·Pamela Royle, Hema Mistry, Peter Auguste, D Shyangdan, Karoline Freeman, Noemi Lois, Norman Waugh	2015	73
4	Effectiveness and cost-effectiveness of traditional and new partner notification technologies for curable sexually transmitted infections: observational study, systematic reviews and mathematical modelling Health Technology Assessment ·Christian L. Althaus, Katy Turner, Catherine H Mercer, Peter Auguste, Tracy Roberts, Gill Bell, Sereina A. Herzog, Jackie Cassell, W. John Edmunds, Katherine M. White, Helen Ward, Nicola Low	2014	71
5	Pulse oximetry as a screening test for congenital heart defects in newborn infants: a cost-effectiveness analysis Archives of Disease in Childhood ·Tracy Roberts, Pelham Barton, Peter Auguste, Lee Middleton, Alexandra Furmston, Andrew K Ewer	2012	59
6	Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling Health Technology Assessment ·Catherine Meads, Peter Auguste, Clare Davenport, S Małysiak, Sudha Sundar, Marta Kowalska, A Zapalska, Peter Guest, Shakila Thangaratinam, Pierre L. Martin‐Hirsch, E Borowiack, Pelham Barton, Tracy Roberts, Khalid S. Khan	2013	44
7	Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation Health Technology Assessment ·Peter Auguste, Alexander Tsertsvadze, Joshua Pink, Rachel Court, Farah Seedat, Tara Gurung, Karoline Freeman, Sian Taylor‐Phillips, Clare Walker, Jason Madan, Ngianga‐Bakwin Kandala, Aileen Clarke, Paul Sutcliffe	2016	40
8	Clinical effectiveness and cost-effectiveness of use of therapeutic monitoring of tumour necrosis factor alpha (TNF-α) inhibitors [LISA-TRACKER® enzyme-linked immunosorbent assay (ELISA) kits, TNF-α-Blocker ELISA kits and Promonitor® ELISA kits] versus standard care in patients with Crohn’s disease: systematic reviews and economic modelling Health Technology Assessment ·Karoline Freeman, Martin Connock, Peter Auguste, Sian Taylor‐Phillips, Hema Mistry, D Shyangdan, Rachel Court, Ramesh Arasaradnam, Paul Sutcliffe, Aileen Clarke	2016	27
9	Evaluating PET‐CT in the detection and management of recurrent cervical cancer: systematic reviews of diagnostic accuracy and subjective elicitation BJOG An International Journal of Obstetrics & Gynaecology ·Catherine Meads, Clare Davenport, S Małysiak, Marta Kowalska, A Zapalska, Peter Guest, Pierre L. Martin‐Hirsch, E Borowiack, Peter Auguste, Pelham Barton, Tracy Roberts, Khalid S. Khan, Sudha Sundar	2013	26
10	Evaluating PET–CT in routine surveillance and follow‐up after treatment for cervical cancer: a cost‐effectiveness analysis BJOG An International Journal of Obstetrics & Gynaecology ·Peter Auguste, Pelham Barton, Catherine Meads, Clare Davenport, S Małysiak, Marta Kowalska, A Zapalska, Peter Guest, Pierre L. Martin‐Hirsch, E Borowiack, Khalid S. Khan, Sudha Sundar, Tracy Roberts	2013	25
11	Valuing the Health States Associated with Chlamydia trachomatis Infections and Their Sequelae: A Systematic Review of Economic Evaluations and Primary Studies Value in Health ·Louise Jackson, Peter Auguste, Nicola Low, Tracy Roberts	2014	24
12	An economic evaluation of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence Health Technology Assessment ·Peter Auguste, P Barton, Christopher Hyde, Tracy Roberts	2011	22
13	Short- and long-term clinical outcomes of use of beta-interferon or glatiramer acetate for people with clinically isolated syndrome: a systematic review of randomised controlled trials and network meta-analysis Journal of Neurology ·Xavier Armoiry, Alan Kan, G. J. Meléndez‐Torres, Rachel Court, Paul Sutcliffe, Peter Auguste, Jason Madan, Carl Counsell, Aileen Clarke	2018	21
14	Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis: systematic review and network meta-analysis of trials including recommended dosages BMC Neurology ·G. J. Meléndez‐Torres, Xavier Armoiry, Rachel Court, Jacoby Patterson, Alan Kan, Peter Auguste, Jason Madan, Carl Counsell, Olga Ciccarelli, Aileen Clarke	2018	20
15	Cost-effectiveness of tumor-treating fields added to maintenance temozolomide in patients with glioblastoma: an updated evaluation using a partitioned survival model Journal of Neuro-Oncology ·Martin Connock, Peter Auguste, Claude Dussart, Jacques Guyotat, Xavier Armoiry	2019	20
16	Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation Health Technology Assessment ·G. J. Meléndez‐Torres, Peter Auguste, Xavier Armoiry, Hendramoorthy Maheswaran, Rachel Court, Jason Madan, Alan Kan, Stephanie Lin, Carl Counsell, Jacoby Patterson, Jeremy Rodrigues, Olga Ciccarelli, Hannah Fraser, Aileen Clarke	2017	20
17	How Do Pharmaceutical Companies Model Survival of Cancer Patients? A Review of NICE Single Technology Appraisals in 2017 International Journal of Technology Assessment in Health Care ·Daniel Gallacher, Peter Auguste, Martin Connock	2019	16
18	Software using artificial intelligence for nodule and cancer detection in CT lung cancer screening: systematic review of test accuracy studies Thorax ·Julia Geppert, Asra Asgharzadeh, Anna Brown, Chris Stinton, Emma Helm, Surangi Jayakody, Daniel Todkill, Daniel Gallacher, Hesam Ghiasvand, Mubarak Patel, Peter Auguste, Alexander Tsertsvadze, Yen‐Fu Chen, Amy Grove, Bethany Shinkins, Aileen Clarke, Taylor Phillips	2024	15
19	A systematic review of economic models used to assess the cost-effectiveness of strategies for identifying latent tuberculosis in high-risk groups Tuberculosis ·Peter Auguste, Alexander Tsertsvadze, Rachel Court, Joshua Pink	2016	12
20	Will the US$5 million onasemnogene abeparvosec treatment for spinal muscular atrophy represent ‘value for money’ for the NHS? A rapid inquiry into suggestions that it may be cost-effective Expert Opinion on Biological Therapy ·Martin Connock, Lazaros Andronis, Peter Auguste, Claude Dussart, Xavier Armoiry	2020	12

About Peter Auguste

Peter Auguste is a scholar working on Radiology, Nuclear Medicine and Imaging, Epidemiology, Obstetrics and Gynecology, Genetics and Economics and Econometrics, having authored 44 papers that have together received 857 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Radiomics and Machine Learning in Medical Imaging (6 papers), Tuberculosis Research and Epidemiology (4 papers), Multiple Sclerosis Research Studies (4 papers), Endometrial and Cervical Cancer Treatments (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Pneumonia and Respiratory Infections (3 papers) and Retinal Diseases and Treatments (3 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (54 citations), Microbiology (61 citations), Epidemiology (338 citations), Infectious Diseases (171 citations) and Ophthalmology (75 citations). Peter Auguste has collaborated with scholars based in United Kingdom, France and Switzerland. Frequent co-authors include Tracy Roberts, Rachel Court, Aileen Clarke, Paul Sutcliffe, Alexander Tsertsvadze, Pelham Barton, Joshua Pink, Hema Mistry, Martin Connock and Karoline Freeman. Their work appears in journals such as Health Technology Assessment, BMJ Open, PharmacoEconomics, BJOG An International Journal of Obstetrics & Gynaecology and International Journal of Technology Assessment in Health Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact